801
Participants
Start Date
July 11, 2017
Primary Completion Date
July 24, 2018
Study Completion Date
July 24, 2018
IDP-123 Lotion
Tazarotene 0.045% Lotion
IDP-123 Vehicle Lotion
Vehicle Lotion
Valeant Site 10, New York
Valeant Site 33, Stony Brook
Valeant Site 43, Rochester
Valeant Site 28, Broomall
Valeant Site 19, Rockville
Valeant Site 21, Charlottesville
Valeant Site 44, Snellville
Valeant Site 02, Miami
Valeant Site 26, West Palm Beach
Valeant Site 05, Boynton Beach
Valeant Site 38, Jupiter
Valeant Site 29, Clearwater
Valeant Site 41, Mobile
Valeant Site 14, Murfreesboro
Valeant Site 18, Knoxville
Valeant Site 32, Louisville
Valeant Site 37, Clinton Township
Valeant Site 20, Fort Gratiot
Valeant Site 30, Clarkston
Valeant Site 08, Bay City
Valeant Site 24, Fridley
Valeant Site 22, Rogers
Valeant Site 11, Oklahoma City
Valeant Site 07, Dallas
Valeant Site 39, Sugar Land
Valeant Site 23, College Station
Valeant Site 04, San Antonio
Valeant Site 27, Pflugerville
Valeant Site 25, Denver
Valeant Site 09, Layton
Valeant Site 15, West Jordan
Valeant Site 42, Albuquerque
Valeant Site 34, Carlsbad
Valeant Site 06, San Diego
Valeant Site 13, San Diego
Valeant Site 31, San Diego
Valeant Site 36, Santa Ana
Valeant Site 12, Fremont
Valeant Site 35, Walla Walla
Valeant Site 03, Morristown
Valeant Site 16, Warwick
Valeant Site 01, Surrey
Valeant Site 45, Winnipeg
Valeant Site 40, Windsor
Valeant Site 17, Saint-Jérôme
Bausch Health Americas, Inc.
INDUSTRY